Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Reneo Pharmaceuticals, Inc. RPHM
$8.15
-$0.3 (-3.72%)
На 18:04, 12 мая 2023
+120.86%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
219187602.00000000
-
week52high
11.30
-
week52low
1.79
-
Revenue
0
-
P/E TTM
-4
-
Beta
1.11065900
-
EPS
-2.13000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 10:59
Описание компании
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 18 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 24 мар 2022 г. |
| Baird | Outperform | 27 янв 2022 г. | |
| HC Wainwright & Co. | Buy | 21 дек 2021 г. | |
| Ladenburg Thalmann | Buy | 22 ноя 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Lam Jennifer | A | 90000 | 90000 | 09 дек 2022 г. |
| Hall Ashley | A | 125000 | 125000 | 09 дек 2022 г. |
| Cruse Michael | A | 125000 | 125000 | 09 дек 2022 г. |
| Dorenbaum Alejandro | A | 125000 | 125000 | 09 дек 2022 г. |
| FLESHER GREGORY J. | A | 300000 | 300000 | 09 дек 2022 г. |
| Cruse Michael | A | 13697 | 7500 | 01 сент 2022 г. |
| GREY MICHAEL G | D | 67406 | 50000 | 31 авг 2022 г. |
| GREY MICHAEL G | A | 50000 | 50000 | 31 авг 2022 г. |
| Cruse Michael | A | 6197 | 3212 | 31 авг 2022 г. |
| Cruse Michael | A | 2985 | 1845 | 30 авг 2022 г. |
Новостная лента
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
GlobeNewsWire
06 сент 2022 г. в 08:35
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company's management team will participate at the following conferences in September, as detailed below: